Inclusive of all taxes
Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets are a specialized pharmaceutical formulation designed for effective diabetes management. Combining three active agents—Voglibose, Glimepiride, and Metformin Hydrochloride—in a sustained-release tablet, this medication provides controlled glucose regulation over an extended period. Manufactured under stringent WHO-GMP standards by IndiGlobal Exports, these tablets ensure high therapeutic efficacy and consistent dosing. The export-quality product is presented in export-grade blister or strip packaging, meeting international pharmaceutical market requirements. Ideal for B2B clients such as hospitals, retail pharmacies, and healthcare institutions, these tablets support comprehensive glycemic control for diabetic patients, enhancing patient compliance via sustained release technology. This formulation complies with pharmacopoeial standards (IP/USP), ensuring safety and reliability for both regulated and semi-regulated global markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Voglibose, Glimepiride, Metformin Hydrochloride |
| Formulation Type | Sustained Release Tablets |
| Indication | Management of diabetes mellitus |
| Dosage Form | Oral tablet |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Packaging | Export-grade blister or strip packs |
| Quality Compliance | IP/USP Pharmacopoeial standards |
| Suitability | Approved for export to international pharmaceutical markets |
| Manufacturer | IndiGlobal Exports |
| Shelf Life | As per regulatory standards |
| Attributes | Description |
|---|---|
| Category | Diabetes Management |
| Therapeutic Class | Antidiabetic Combination |
| Active Pharmaceutical Ingredients (APIs) | Voglibose, Glimepiride, Metformin Hydrochloride |
| Sustained Release | Yes, formulated for extended glucose control |
| Tablet Weight | As per manufacturer’s specification |
| Packaging Options | Blister packs or strip packs suitable for bulk export |
| Shelf Life | Compliant with export regulatory norms (typically 24 months) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Compliance | Manufactured under WHO-GMP, IP/USP standards |
| Intended Use | For clinical treatment and ongoing diabetes care |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The sustained-release formulation ensures gradual and controlled release of Voglibose, Glimepiride, and Metformin Hydrochloride, resulting in prolonged blood glucose control and improved patient compliance by reducing dosing frequency.
Yes, the tablets are manufactured in WHO-GMP compliant facilities and adhere to IP/USP pharmacopoeial standards, ensuring quality and compliance for international pharmaceutical markets.
The product is packaged in export-grade blister or strip packs, suitable for bulk shipments and institutional supply chains to meet export market requirements.
Yes, the tablets are suitable for prescription use in hospitals as well as retail pharmacies, facilitating broad accessibility for diabetes treatment.
The tablets should be stored in a cool, dry place away from direct sunlight, following the recommended storage conditions to preserve quality and shelf life.
Brand: indiglobal exports
Country Of Origin: India
Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
